Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in Episodic or Chronic Cluster Headache
NCT00203190Phase 4Terminated
- Sponsor
- Thomas Jefferson University
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Cluster Headache (CH) comparing Topiramate with Placebo (2 arms). Primary endpoint: Change in the average daily frequency of moderate or severe attacks. Started Sep 2004; status: terminated.
02
Drugs
topiramate
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NCT00203190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00203190.